achieved. This circumstance I view to be true throughout academic surgical enterprise.
During internship, Dr. Norman Shumway and I did a series of pre-and postoperative Evans blue blood volume studies. After internship I joined George Moore's laboratory group studying localization of brain tumors. We used fluorescent-tagged molecules, which localized brain tumors associated with blood-brain barrier leakage. A batch of 131 I albumin arrived one day in 1950 for our brain tumor studies and seemed an ideal substance to measure blood volumes. We consulted the Therapeutic Radiology Department, who helped us build a Geiger counter for counting 131 I gamma rays. This resulted in our first paper before the surgical forum of the American College of Surgeons meeting in 1951. 1, 2 I had been sent to Union College in the Navy U-12 program. When the Korean War broke out, the Army needed more physicians. I was one of the 500 naval physicians "given" temporarily to the Army. On return to the Naval Service, they gave me to the Marines for a year, which I spent in the Far East as one of 21 surgeons assigned to surgical teams. Each team consisted of a general surgeon, orthopedist, anesthesiologist, and 10 corpsmen. Four among the Marine surgeons that I knew became surgical chairmen: Frank Spencer, Keith Reestma (unfortunately recently deceased), Arthur Donovan, and myself.
One year after returning to Minnesota to resume my residency, I had the good fortune to be senior resident on the Cardiac Service at the advent of open-heart surgery. This heady experience was followed by an opportunity to go to the experimental surgery laboratory of Drs. Lillehei and Varco.
In 1954, Dr. Wangensteen enticed a pair of brothers, one of whom had coronary artery disease, to donate $200,000 to the department to do research on this problem. Dr. Wangensteen turned to Dr. Lillehei, who in turn gave the project to Dr. Absolon and myself. Dr. Absolon had dissected the coronary arteries of patients dying from acute coronary occlusion and noted that a high percentage of the blocks were in the proximal coronary artery. He proposed to address the problem by endarterectomy, while the remainder of our team chose to attempt bypass of the ligated left coronary artery with the internal mammary artery anastomosed to the circumflex coronary artery. This was accomplished in over 25 dogs without cardiac bypass on a beating heart. About one third survived the procedure. We published our thoughts in Surgery, Gynecology & Obstetrics in 1956. 3 Clinical application had to await the development of coronary angiography a decade later.
Following this experience, I met Dr. Wangensteen in the hall one day. He asked, "Are you going to be a heart surgeon or cancer surgeon?" I responded that I intended to be an academic surgeon. He concluded our conversation with the terse response, "You're going to be a cancer surgeon." Left unsaid was the hidden message, "If you want to stay on the faculty." He felt he had a surfeit of cardiac surgeons already on the faculty.
Our surgical training was segmented by time devoted to full-time research in the experimental laboratory or basic sciences alternating with rotations on the clinical services.
The years 1955 to 1957 were spent in the Physiology Department working with Dr. Maurice Visscher and Dr. Carlos Martinez.
With Dr. Visscher I was among those who studied endotoxin shock. My thesis was entitled "The Kinetics of Distribution of Various Tagged Substances (of blood, plasma, extracellular space and total body water) in Endotoxin Shock." This work led us to pioneer a useful clinical tool, the use of flow-limited substances such as D 2 0 (heavy water) and antipyrine, whose rate of transfer through the capillary into the surrounding tissues was limited only by the rate of blood flow. Later, radiolabeled krypton was used to measure blood flow by the exact reverse approach (i.e., the rate at which injected krypton leaves the tissue is a function of blood flow rate). Several papers and one Ph.D. thesis resulted from this application. 4 -7 With Dr. Carlos Martinez, we studied the phenomena of acquired tolerance in inbred mice using both tumors and skin grafts. We reasoned that those factors facilitating grafting would be favorable to cancer growth and, conversely, that factors thwarting grafting might give clues to developing immune therapy for cancer. Obviously this was a simplistic view, but at the time not unreasonable. This ultimately led to the hypothesis that persistence of foreign antigen was the key element in maintaining acquired tolerance. This was especially clear in our studies of F1 hybrid adult mice when parabiosed to either parental strain, the parent strain, would accept the other strain's tissues. Today, one of the promising areas of research in acquired tolerance uses hybridoma cell lines. Our paper, presented before the American Surgical Association, was published in Annals of Surgery in 1965. 8, 9 There were only three tenure-track positions available in general surgery at the University of Minnesota. However, there was a much larger full-time faculty made up of Markle scholars and scholars of the American Cancer Society, which supported junior faculty positions for 5 years each. I was fortunate to receive such a scholarship from the American Cancer Society, which thereby enabled me to join the faculty.
After joining the faculty in 1957, we were greatly intrigued by Dr. Creech and colleagues' work on isolated perfusion cancer chemotherapy, and we embarked on a major clinical and research effort to develop this technique. Our research studied the various parameters of blood flow, oxygen saturation, and temperature for optimal performance of the chemotherapeutic agents, namely nitrogen mustard and 5-fluorouracil (5-FU). The technique was associated with some truly outstanding responses; however, the majority of tumors did not succumb to the concept that if a modest dose is slightly effective, a larger dose will be much more effective. The technique lays somewhat dormant today except for in-transit melanoma metastases, though more effective agents may possibly make this technique viable in the future. 10 I suspect this foray into surgical chemotherapy attracted the attention of Dr. Tony Curreri from the University of Wisconsin, who was forming a group of surgeons to implement the use of 5-FU to treat solid tumors. This drug was developed at the University of Wisconsin to treat an experimental liver adenocarcinoma. The Central Oncology Group (COG) was our first involvement with a group of investigators larger than three or four team members. Our studies with 5-FU constituted the backbone of chemotherapy for solid tumors, but proved most effective in breast tumors and was enhanced by the addition of other chemotherapy agents in combinations.
The years at the University of Minnesota were productive ones for our research laboratories. Clinical cancer research, teaching, and surgical practice were both exciting and professionally rewarding. Over 100 papers were published on a broad spectrum of subjects ranging from heart surgery to shock, to transplantation, tissue blood flow, cancer chemotherapy, and even hemicorporectomy. This Minnesota era produced Ph.D. theses for Dr. Waid Rogers and Dr. Tawfik Tamimi. One fellow, Dr. Robert Ausman, never finished surgical training but ended up as vice-president for research of Travenol-Baxter. One medical student, Dr. Ronald Guttmann, went into academic medicine and has been the longtime head of transplantation at McGill University. Another student, Judson Sheridan, became a Rhodes Scholar and ultimately chairman of a cellular biology department, then provost at a large Midwestern university. Numerous residents who spent time in our laboratories went on to academic careers.
In 1965, the newly appointed dean at the South Texas Medical School, Dr. Carter Pannill, showed me a large field with two silos on it at the edge of San Antonio. He said it was going to be the site of a new University of Texas Medical School, and asked if I wanted to become the Chair of Surgery. The offer to help start a new medical school and develop the Department of Surgery was too good an opportunity to pass up. True to form, it became a team effort. Six Minnesotans (none native to that state) joined me in this enterprise: Dave Root, Waid Rogers, Arthur McFee, Tony Cruz, Carlos Pestana, and Jim Story. All of them stayed to the present or retirement, a minimum of 30 years. Our first problem, aside from building a new hospital, designing a medical school curriculum, and developing approved residency programs, was the fact that San Antonio had 250,000 medically indigent patients and we were the primary source for their surgical care. Within 5 years, Residency Review Committee-approved training programs were established in surgery, orthopedics, thoracic surgery, urology, neurosurgery, plastic surgery, ophthalmology, otolaryngology, and oral surgery.
Opening of the Audie Murphy Veterans Administration Hospital in 1973 afforded an opportunity to enlarge both our faculty and residency numbers. Four new general surgery faculty (Drs. Wayne Schwesinger, Carey Page, Barry Levine, and Ken Sirinek) facilitated both clinical and research activity in our department. Dr. Mary Pat Moyer, microbiologist, established a research laboratory studying colon cancer cell growth.
In 1978, it became clear that our hospital's record-keeping system lacked sophistication. Dr. Carey Page accepted the responsibility for running our Morbidity & Mortality Conference. A very methodical fellow, he suggested developing a computerized record of operation, preoperative risk factors, preoperative lab data, and postoperative complications, termed SPOC for surgical program operative cases. This went on-line for general surgery at both the Audie Murphy Veterans Administration and University Hospitals in 1978 and has been a most useful tool in our ability to record our data and report our experiences in the literature.
Our first paper before the Southern Surgical Association, my new member paper entitled "Gastric Devascularization," 11 did not win the Shipley Award that year. That honor belonged to Josh Jurkiewicz, the bald-headed surgeon who sits in the front row with me at almost every Southern Surgical Association meeting. J. David Richardson, my coauthor, later won the Shipley Award for his new member paper. History attests to the success of our venture. Over 2,000 published papers (an average of 73 per year), 309 residents trained, and 4,066 medical school graduates constitute the products of our enterprise. Among the 159 general surgeons trained, approximately one third stayed in San Antonio, one third disbursed throughout the rest of Texas, and one third scattered throughout the U.S.A. Thirteen have remained in academic surgery.
The eighties ushered in my personal involvement in national surgical responsibilities. Election to the American College of Surgeons Board of Governors, and Chairman for 2 years, gave me an opportunity to play a role in developing stronger liaison between the fellowship and the regents and firmly established socioeconomic involvement as a major factor, in addition to continuing education, as an American College of Surgeons' responsibility on behalf of the fellowship. This was facilitated by a program initiated by Dr. Oliver Beahrs. The governors report their constituent fellows' concerns to the regents, our governing board. They in turn respond to the governors regarding regental actions taken in response to the fellows' concerns.
Appointment as a Director of the American Board of Surgery provided an opportunity to share responsibilities for setting the training requirements for residents. The scope, depth, and amount of experience necessary to maintain the quality of surgeons to serve our nation's needs claimed our continued scrutiny. I served on the in-training examination committee, whose primary focus was to ensure that the sciences basic to both current and future surgical practice were being covered. The esprit and dedication of the board of surgery directors to their goal of maintaining the highest quality of surgical training was one of my most satisfying experiences.
Being appointed concurrently as one of the American Board of Surgery representatives on the Residency Review Committee provided an opportunity, along with appointees from the American College of Surgeons and the American Medical Association, to set standards for training programs in surgery. A persistent concern was the objective measurement of program deficiencies. Fairness and reproducibility of evaluations required the establishment of objective numerical standards. While most decry the use of numbers of cases as a sole criterion, it was necessary to establish minimal exposure to experience with difficult surgical procedures and to ensure adequate experience carrying out operations on solid organs, blood vessels, and the GI tract. These goals were accomplished.
In 1985, Congress passed a law requiring that the Veterans Administration system investigate all Veterans Administration Hospitals having postoperative mortality and morbidity rates that deviated from prevailing national standards. I was appointed to a national committee to study this problem. We explored several national databases involving over 830,000 cases, including over 300,000 VA cases, to find a statistically valid fit for our VA patient population. None of these proved suitable. The VA experience was comparable in mortality in 105 of 113 procedures. 12 VA hospital results were better than non-VA hospitals for three procedures and worse than others for five procedures. Such results would be expected with a bell-shaped distribution. The quality of information we required, however, was not available in any outside database. In 1989, after Shukri Khuri joined our task force, we decided that we needed to establish internal mechanisms for measuring quality in the VA. 13 Although Dr. Carey Page's database had been in operation since 1978, it was not transferable at that time; however, a very similar database system was developed for the VA population.
We hoped to find generic factors which might account for the differences in operative mortality experienced by various surgical services. Nothing appeared immediately; however, on achieving data collection for over 100,000 cases, the generic factors now became so obvious that our statisticians could actually calculate the expected mortality for any particular patient when given his spectrum of risk factors. The most important element found to relate to Vol. 233 • No. 5
Odyssey of an Academic Surgeon increased mortality was the serum albumin. Then followed ASA classification, disseminated cancer, emergency operation, ascites, age, BUN, SGOT, functional status, platelets, weight loss greater than 10%, and operative complexity. Please note that operative complexity does not even enter this equation until after the 10th item, and a c-index ϭ 0.89 has already been established. 14 The implications are very clear. It is the individual patient's risk factors brought to the operating table that largely determine the outcome of the surgical procedure. This is certainly true for general surgery. In other specialties, operative complexity enters the equation at a higher level and may play a greater role in determining operative mortality. I think this is truer in developing fields, when the optimal technical details are being worked out.
This knowledge has become a very useful tool for evaluating surgical services within the VA system. We know the average operative mortality for the entire VA system. We can calculate the expected operative mortality for each operative case based on the patient risk factors, and we can then calculate an observed/expected mortality ratio for any given operative service. This is just as applicable to individual operations as to an entire service's operations, provided there are sufficient numbers for statistical validity.
A plot of observed/expected ratios revealed that the vast bulk of services varied little from the mean, but some services tailed off with higher, and some with lower, ratios. When we calculated the average of the low ratio tail, 0.57, and compared it to the high ratio tail, 1.48, the best-performing services had only half the expected mortality and the worst services only 50% greater mortality. When we corrected for risk factors, only 10 of the 17 services with the highest crude mortality remained high. Conversely, when evaluating low outliers, only 4 of 12 services remained in the lowest group. Overall, outlier status either high or low would be ascribed incorrectly to 25 of 39 hospitals if observed mortality rates were used, an error rate of 64%. 15 From this data we can conclude that unadjusted mortality is a poor tool for evaluating programs and individual operative mortality. Furthermore, within the VA system the vast bulk of specific mortality findings varied very little from the mean for the system, indicating a comparable degree of performance. Only 2 services out of the 123 have appeared at the highest observed/expected ratio for more than 2 years in a row. A major factor to consider too is that 95% of all the surgical procedures at VA hospitals listed a resident as the operating surgeon.
Should all this be a surprise? I think not. For me, the important factors in surgical success relate to the judgment decisions the attending faculty controls: namely, who, when, what. The "who" includes most of the risk factors the patient brings to the operation. Attempting operation on a patient suffering pancreatic carcinoma with demonstrable celiac axis nodes and bilateral liver metastases on CT scan with a low albumin level results in predictably high mortality.
The "when" includes consideration of those factors that are amenable to change. Changing an alb from 2 up to 3.5, or an ASA class from 4 to 2, may make a real difference in outcome. Should we operate when a bleeding duodenal ulcer patient has lost 4 bottles of blood in 4 hours, or after losing 12 bottles in 12 hours?
"What" to do: pack a major bleeding liver laceration, or spend 4 hours and 30 bottles of blood trying to control the bleeding? As my mentor Dr. Wagensteen would say, "The patient needs a life preserver, not a swimming lesson." I believe that surgical technique is probably overrated among surgeons as a factor in mortality. Once operative techniques for a given procedure are standardized, what one surgeon can do, another can be trained to duplicate. To be sure, there are a few technical virtuosos who, like some violinists, demonstrate dazzling skills. The well-trained product of our residency programs should be compulsive and neat but should not expect applause.
Surgeons should be taught to practice surgery, not operations: how to cut, dissect, suture; how to deal with the various tissues, gut, liver, pancreas; how to use the various tools that have been developed besides the knife and the scissors (to include the Bovie, staplers, and more recently endoscopes and laparoscopes). The key to surgery is judgment (namely, who to operate on, what to do, when to do it) carried out by a well-trained, competent surgeon. The results of this VA database analysis convince me that our training programs produce such surgeons.
One of our present concerns is whether we can translate the VA risk formula to evaluate other hospital databases. We recognize that the VA system has a different population base, mainly middle-aged to elderly males. Can this data be applied successfully to populations of women, children, or trauma centers?
We have been collecting data since 1978 with a similar, but not exact, computerized database. We thought it might be useful to compare our experience. Unfortunately, our database presented insurmountable obstacles to making comparisons. The vast trauma load did not include many of the important risk factors such as albumin, BUN, functional status, SGOT, or ascites. Pediatric patients presented the age problem. The VA formula for risk relates only increasing age with increased operative mortality. Among pediatric patients, all deaths aside from trauma occurred in the first month of life.
From our 90,000-case database, we were able to glean 10,965 cases which shared database elements with the VA database. This included 8,600 university hospital and 2,365 VA cases. The common items were alb, ASA class, BUN, Ca, age, emergency, WBC 1 , WBC 2 , from which the VA statisticians were able to develop a risk-adjusted formula for mortality with a c-index of 0.90. Note that operative complexity is not a component of this formula.
A comparison of deaths, observed versus expected, gave ratios of 0.49 for the entire 10,965 patients, 0.57 for VA patients, and 0.44 for university hospital patients. This suggests that the formula for risk adjustment can be applied to patient groups outside the VA.
To give you an impression of albumin's role in determining risk, of the 10,965 patients mentioned above who had albumin measured, there were 209 deaths, or 1.9%. Of the 209 deaths, 11% had an albumin of 2 mg%, 35% had an albumin of 2.5, and 61% had an albumin of 3.
Since the VA study determined that surgeons are not the major factor in overall mortality, we hoped to find a correlation between surgical complications and surgical services. However, statistical analysis of the VA database of over 500,000 cases has not reached the reliability of risk-adjusted mortality. Yet we surgeons intuitively connect a higher complication rate to poor surgical care, as evidenced by our reliance on morbidity and mortality conferences as a quality control mechanism.
I have detailed a career spanning the gamut from surgical research, after the model of Claude Bernard, to controlled randomized clinical trials of cancer therapy cooperative protocols, followed by statistical or epidemiologic evaluation of a large patient database, seeking important answers to improving patient care. At this point I would like to encourage this surgical audience to participate in the National American College of Surgeons Oncology Group, a cooperative studies group, to help answer continuing surgical questions regarding the role of surgery and chemotherapy in the treatment of cancer. Headed by Dr. Wells, this endeavor deserves our wholehearted support.
My objective has been to emphasize the teamwork so essential to both training surgeons and maintaining research momentum. Academic surgeons have, by necessity, committed themselves to the concept of the team approach to education, training, research, and patient care. It is not a democratic process since there is usually a captain of the team. He serves as the mentor and chooses his teams, sets their goals, supports their personal development, then sends them out to practice or remain in academia, where they in turn assume the mantle of mentorship for those who follow. As I mentioned earlier, it is extremely rare today to find a single-author paper.
It might seem that I have presented a picture so desirable that all trainees would aspire to such an opportunity. Not so. It is a very inefficient, time-consuming method for practice and patient care when compared to solo or surgical group practice. Academic responsibilities also include securing funding to develop research ideas, and convincing younger colleagues of the joys of research and discovery so that they will play on your team. Academic careers often involve external participation with faculty of other institutions to form groups to carry out controlled clinical trials and to answer questions that can only be answered by larger numbers of comparably diseased patients, numbers that are unavailable to a single institution. Almost all regulatory bodies impacting surgery are dominated by academic mem-bers. Why, you might ask? Because of the availability of team members to maintain surgical activity at their home bases, academic surgeons can commit time to these important concerns. A private practitioner rarely has the flexibility to allow the many days away from practice that are required in order to accept board membership responsibilities.
The fields of cardiac, transplantation, and vascular surgery all derived from academic center team efforts during the past half-century. The only major advance I can think of not deriving from academic centers is that of laparoscopic surgery.
Finally, I would be remiss if I did not pay tribute to the most important team of my life-that is, my family. My devoted wife Connie and our six children tolerated and supported my surgical career in so many uncounted ways, long hours in the hospital during surgical training, and long hours after training. Short, primarily camping and skiing vacations kept us close. I tried to be home for dinner by 6:30 each evening before going back for final rounds, but that did not always happen. My family's unselfish support made my odyssey possible; I am forever in their debt.
I must now bring this odyssey to a close. It has been a marvelous 50 years, and for me a golden age of surgery. I am deeply indebted to all my teammates, both mentors and colleagues, who have shared this odyssey with me. This presentation serves to acknowledge those teammates' pivotal role in my journey as an academic surgeon. I am especially honored by the opportunity to have served as your president. Thank you very much.
